UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

AC220 (Quizartinib) Can Be Safely Combined With Conventional Chemotherapy In Older Patients With Newly Diagnosed Acute Myeloid Leukaemia: Experience From The AML18 Pilot Trial

Burnett, AK; Bowen, D; Russell, N; Knapper, S; Milligan, D; Hunter, AE; Khwaja, A; ... Hills, RK; + view all (2013) AC220 (Quizartinib) Can Be Safely Combined With Conventional Chemotherapy In Older Patients With Newly Diagnosed Acute Myeloid Leukaemia: Experience From The AML18 Pilot Trial. In: (Proceedings) 55th Annual Meeting of the American-Society-of-Hematology. AMER SOC HEMATOLOGY

Full text not available from this repository.
Type: Proceedings paper
Title: AC220 (Quizartinib) Can Be Safely Combined With Conventional Chemotherapy In Older Patients With Newly Diagnosed Acute Myeloid Leukaemia: Experience From The AML18 Pilot Trial
Event: 55th Annual Meeting of the American-Society-of-Hematology
Location: New Orleans, LA
Dates: 07 December 2013 - 10 December 2013
Keywords: Science & Technology, Life Sciences & Biomedicine, Hematology
UCL classification: UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology
URI: http://discovery.ucl.ac.uk/id/eprint/10029409
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item